首页> 外国专利> positive inotropische and lisitropische 3.5 - dihydroimidazo 2.1 - b chinazolin - 2 (1h) - on derivatives.

positive inotropische and lisitropische 3.5 - dihydroimidazo 2.1 - b chinazolin - 2 (1h) - on derivatives.

机译:阳性正性肌力和正性肌力3.5-二氢咪唑并[2.1-b]中国唑啉-2(1h)-衍生物。

摘要

Positive inotropic and lusitropic 3,5-dihydroimidazo[2,1-b]quinazolin-2(1H)-one derivatives of formula CHEM the pharmaceutically acceptable addition salts and stereochemically isomeric forms thereof, wherein R is hydrogen, C1-6alkyl, phenyl; substituted phenyl; pyridinyl; or thienyl optionally substituted with halo or C1-6alkyl; R1 is hydrogen of C1-6alkyl; R2 is hydrogen, C1-6alkyl, hydroxyC1-6alkyl or phenyl; or R1 and R2 taken together may also form a C1-5alkanediyl radical; X is a radical of formula =O (a), =N-O-R3 (b),or =CH-R4 (c); R3 is hydrogen, tri(C1-6alkyl)silyl or C1-6alkyl optionally substituted with COOH, COOC1-4alkyl, CONR5R6 or COOCH2CONR7R8; R4 is COOH, COOC1-4alkyl, CONR5R6, COOCH2CONR7R8 or C1-6alkyl optionally substituted with COOH, COOC1-4alkyl, CONR5R6 or COOCH2CONR7R8. Pharmaceutical compositions containing said compounds as an active ingredient. Methods of preparing said compounds and pharmaceutical compositions.
机译:的正性和正性的3,5-二氢咪唑并[2,1-b]喹唑啉-2(1H)-一衍生物及其药学上可接受的加成盐和立体化学异构形式,其中R为氢,C 1-6烷基,苯基取代苯基吡啶基噻吩基任选地被卤素或C 1-6烷基取代; R 1为C 1-6烷基的氢。 R 2为氢,C 1-6烷基,羟基C 1-6烷基或苯基;或者R 1和R 2一起也可以形成C 1-5烷二基。 X是式= O(a),= N-O-R 3(b)或= CH-R 4(c)的基团; R 3是氢,任选被COOH,COOC1-4烷基,CONR 5 R 6或COOCH 2 CONR 7 R 8取代的氢,三(C 1-6烷基)甲硅烷基或C 1-6烷基; R 4为COOH,COOC1-4烷基,CONR 5 R 6,COOCH 2 CONR 7 R 8或任选被COOH,COOC1-4烷基,CONR 5 R 6取代的C 1-6烷基或COOCH 2 CONR 7 R 8。包含所述化合物作为活性成分的药物组合物。制备所述化合物和药物组合物的方法。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号